oleanolic acid has been researched along with natriuretic peptide, brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cachofeiro, V; Cordova, C; Gutierrez, B; Martín, R; Nieto, ML; San Román, JA | 1 |
| Bakris, GL; Chertow, GM; Chin, MP; de Zeeuw, D; Goldsberry, A; Linde, PG; McCullough, PA; McMurray, JJ; Meyer, CJ; Wittes, J; Wrolstad, D | 1 |
1 trial(s) available for oleanolic acid and natriuretic peptide, brain
| Article | Year |
|---|---|
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.
Topics: Aged; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Termination of Clinical Trials; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Oleanolic Acid; Patient Safety; Predictive Value of Tests; Reference Values; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Survival Rate; Treatment Outcome | 2014 |
1 other study(ies) available for oleanolic acid and natriuretic peptide, brain
| Article | Year |
|---|---|
Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Body Weight; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Proliferation; Female; Fibroblasts; Humans; Immunomodulation; Interleukin-10; Interleukins; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oleanolic Acid; Organ Size; Peptides; T-Lymphocytes, Regulatory | 2014 |